Condensed Consolidated Statements of Shareholders' Equity (unaudited) - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-In-Capital
Additional Paid-In-Capital
Cumulative Effect, Period of Adoption, Adjustment
Treasury Stock
Retained Earnings
Retained Earnings
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2019 $ 2,261,332 $ (1,609) $ 7 $ 379,380   $ (72,455) $ 1,955,187 $ (1,609) $ (787)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Share-based compensation 3,790     3,790          
Repurchase of common stock (1,536)         (1,536)      
Proceeds from options exercised 16     16          
Changes in comprehensive income 226               226
Net loss (27,828)           (27,828)    
Ending balance at Mar. 31, 2020 $ 2,234,391   7 383,186   (73,991) 1,925,750   (561)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Accounting Standards Update [Extensible List] save:AccountingStandardsUpdate2020-06Member                
Beginning balance at Dec. 31, 2019 $ 2,261,332 (1,609) 7 379,380   (72,455) 1,955,187 (1,609) (787)
Ending balance at Dec. 31, 2020 2,249,695 $ (49,530) 10 799,549 $ (55,590) (74,124) 1,524,878 $ 6,060 (618)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Share-based compensation 4,254     4,254          
Repurchase of common stock (1,307)         (1,307)      
Changes in comprehensive income 52               52
Issuance of warrants 2,146     2,146          
Net loss (112,321)           (112,321)    
Ending balance at Mar. 31, 2021 $ 2,092,989   $ 10 $ 750,359   $ (75,431) $ 1,418,617   $ (566)